Apogee Acquires Cumulus Technology Services Inc. to Enhance Managed Technology Services Leadership Position in Higher Education
Acquisition Extends Apogee Networking and IT Expertise into Secure Cloud Services, Building on Commitment to…
Enterprise Resource Planning
insightsoftware Takes Jet Analytics to the Cloud
Adopting a new SaaS model, Jet Analytics Cloud is delivered via Microsoft Azure to provide…
W Energy Software Hires New CEO
Seasoned Energy and Software Executive Rachel Collins to Lead Next Phase of Growth and Innovation…
Replimune Announces Positive Initial Data from the Anti-PD1 Failed Melanoma Cohort of the IGNYTE Clinical Trial & an RP2/3 Program Update
RP1 combined with nivolumab continues to demonstrate deep and durable responses in patients with anti-PD1…
Todos Medical to Present at the RHK 2022 Disruptive Growth Conference
New York, NY, and Tel Aviv, ISRAEL, Dec. 06, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Todos Medical,…
City of Fairfax, Virginia, Selects Tyler Technologies’ Enterprise Resource Planning Solution
Solution to help city strengthen transparency to constituents PLANO, Texas–(BUSINESS WIRE)–$TYL #TylerTech—Tyler Technologies, Inc. (NYSE:…
Rimini Street Launches Rimini Connect™ to Help Organizations Future-Proof and Solve Continuously Evolving and Growing Integration and Interoperability Challenges
New, easy-to-deploy suite of integration and interoperability solutions provides unique, innovative, and economical tools for…
AWS Announces AWS Supply Chain
New cloud application improves supply chain visibility and delivers actionable insights to mitigate supply chain…
AWS Announces Two New Capabilities to Move Toward a Zero-ETL Future on AWS
Amazon Aurora zero-ETL integration with Amazon Redshift enables customers to analyze petabytes of transactional data…
Palisade Bio is Granted Fast Track Designation from the U.S. Food and Drug Administration for LB1148 for Accelerated Return of Bowel Function following GI Surgery
Carlsbad, CA, Nov. 22, 2022 (GLOBE NEWSWIRE) — Palisade Bio, Inc. (Nasdaq: PALI), a clinical stage biopharmaceutical…
Alcon Completes Acquisition of Aerie Pharmaceuticals, Inc., Strengthening Company’s Ophthalmic Pharmaceutical Business
Leveraging Alcon’s robust commercial capabilities and resources to drive further growth and access to Rocklatanand…
Alcon Completes Acquisition of Aerie Pharmaceuticals, Inc., Strengthening Company’s Ophthalmic Pharmaceutical Business
Leveraging Alcon’s robust commercial capabilities and resources to drive further growth and access to Rocklatanand…
Central Garden & Pet Announces Q4 and Fiscal 2022 Financial Results
Fiscal 2022 net sales increased 1% to $3.3 billion Fiscal 2022 diluted EPS increased 2%…
Harris Williams Advises Bregal in Connection with the Combination of Four Portfolio Companies to Form GENII Software Group
LONDON–(BUSINESS WIRE)–Harris Williams, a global investment bank specializing in M&A advisory services, announces it advised…
Tilray Launches ‘Take Back Control’ Platform to Provide Women With Free Medical Cannabis Resources
LEAMINGTON, Ontario, Nov. 18, 2022 (GLOBE NEWSWIRE) — Tilray Brands, Inc. (“Tilray” or the “Company”)…
Vizient Announces Strategic Partnership with HANDLE Global to Launch Capital Asset Management System
IRVING, Texas–(BUSINESS WIRE)–Vizient, Inc. today announced it has entered into a strategic partnership with HANDLE…
Donna de Winter Named as one of the Top 50 Women Leaders in SaaS 2022 by The Software Report
TORONTO–(BUSINESS WIRE)–Q4 Inc. (TSX: QFOR) (“Q4” or “the Company”), a leading capital markets communications platform…
Vasta Announces Third Quarter 2022 Results
SÃO PAULO–(BUSINESS WIRE)–Vasta Platform Limited (NASDAQ: VSTA) – “Vasta” or the “Company” announces today its…
Masonite International Corporation Reports Third Quarter Sales and Earnings Growth
Net sales up 12% year over year on strong execution in North American Residential segment…
Altimmune to Present Pemvidutide Clinical Data at the Upcoming AHA Scientific Sessions and AASLD The Liver Meeting®
GAITHERSBURG, Md., Oct. 28, 2022 (GLOBE NEWSWIRE) — Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical…